Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Nutrigenomics Market, by Product
1.4.2 Europe Nutrigenomics Market, by End User
1.4.3 Europe Nutrigenomics Market, by Application
1.4.4 Europe Nutrigenomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Nutrigenomics Market by Product
4.1 Europe Reagents & Kits Market by Country
4.2 Europe Services Market by Country
Chapter 5. Europe Nutrigenomics Market by End User
5.1 Europe Hospitals & Clinics Market by Country
5.2 Europe Online Platforms Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Nutrigenomics Market by Application
6.1 Europe Obesity Market by Country
6.2 Europe Diabetes Market by Country
6.3 Europe Cardiovascular Diseases Market by Country
6.4 Europe Cancer Research Market by Country
Chapter 7. Europe Nutrigenomics Market by Country
7.1 Germany Nutrigenomics Market
7.1.1 Germany Nutrigenomics Market by Product
7.1.2 Germany Nutrigenomics Market by End User
7.1.3 Germany Nutrigenomics Market by Application
7.2 UK Nutrigenomics Market
7.2.1 UK Nutrigenomics Market by Product
7.2.2 UK Nutrigenomics Market by End User
7.2.3 UK Nutrigenomics Market by Application
7.3 France Nutrigenomics Market
7.3.1 France Nutrigenomics Market by Product
7.3.2 France Nutrigenomics Market by End User
7.3.3 France Nutrigenomics Market by Application
7.4 Russia Nutrigenomics Market
7.4.1 Russia Nutrigenomics Market by Product
7.4.2 Russia Nutrigenomics Market by End User
7.4.3 Russia Nutrigenomics Market by Application
7.5 Spain Nutrigenomics Market
7.5.1 Spain Nutrigenomics Market by Product
7.5.2 Spain Nutrigenomics Market by End User
7.5.3 Spain Nutrigenomics Market by Application
7.6 Italy Nutrigenomics Market
7.6.1 Italy Nutrigenomics Market by Product
7.6.2 Italy Nutrigenomics Market by End User
7.6.3 Italy Nutrigenomics Market by Application
7.7 Rest of Europe Nutrigenomics Market
7.7.1 Rest of Europe Nutrigenomics Market by Product
7.7.2 Rest of Europe Nutrigenomics Market by End User
7.7.3 Rest of Europe Nutrigenomics Market by Application
Chapter 8. Company Profiles
8.1 Genova Diagnostics
8.1.1 Company Overview
8.1.2 SWOT Analysis
8.2 Metagenics, Inc.
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Acquisition and Mergers:
8.2.3 SWOT Analysis
8.3 Nutrigenomix Inc.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.2.2 Product Launches and Product Expansions:
8.3.3 SWOT Analysis
8.4 Unilever PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 SWOT Analysis
8.5 The Gene Box
8.5.1 Company Overview
8.5.2 SWOT Analysis
8.6 Cura Integrative Medicine
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 Fagron Genomics S.L.U. (GX Sciences Inc.)
8.7.1 Company Overview
8.7.2 SWOT Analysis
8.8 Xcode Life Sciences Private Limited
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Product Launches and Product Expansions:
8.8.3 SWOT Analysis
8.9 DNA Life
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. BASF SE
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis
Unique Offerings 